RA
ABMD

Royce & Associates’s Abiomed Inc ABMD Stock Holding History

Royce & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,000
Closed -$818K – 1236
2018
Q2 		$818K Sell
2,000
-8,000
-80% -$2.9M 0.01% 976
2018
Q1 		$2.91M Hold
10,000
– – 0.02% 746
2017
Q4 		$1.87M Sell
10,000
-10,000
-50% -$1.87M 0.01% 867
2017
Q3 		$3.37M Hold
20,000
– – 0.02% 697
2017
Q2 		$2.87M Buy
20,000
+3,000
+18% +$403K 0.02% 753
2017
Q1 		$2.13M Buy
17,000
+7,000
+70% +$811K 0.01% 841
2016
Q4 		$1.13M Buy
+10,000
New +$1.16M 0.01% 921

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return